The systemic face of airway diseases: the role of C-reactive protein

Wouters E. F. M.

Source: Eur Respir J 2006; 27: 877-879
Journal Issue: May
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Wouters E. F. M.. The systemic face of airway diseases: the role of C-reactive protein. Eur Respir J 2006; 27: 877-879

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients
Source: Eur Respir J 2006; 27: 902-907
Year: 2006



Coexisting chronic diseases in COPD – cause of elevated level of C-reactive protein?
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007


High sensitivity C-reactive protein in asthma
Source: Eur Respir J 2006; 27: 908-912
Year: 2006



Plasma CRP levels correlate with markers of airway inflammation after lung transplantation: a role for systemic inflammation in bronchiolitis obliterans syndrome?
Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation
Year: 2008



C-reactive protein in pulmonary tuberculosis-correlation with extent and severity of the disease
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012


The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 363s
Year: 2007

Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?
Source: Eur Respir J 2008; 32: 1451-1457
Year: 2008



Body composition and plasma levels of inflammatory biomarkers in COPD
Source: Eur Respir J 2010; 36: 1027-1033
Year: 2010



Highly sensitive C-reactive protein: is it a predictor of airway disease severity in mustard lung patients?
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009


Plasma C-reactive protein, pulmonary function and bronchial hyperresponsiveness. A population-based study
Source: Eur Respir J 2003; 22: Suppl. 45, 295s
Year: 2003

C-reactive protein and childhood asthma
Source: Annual Congress 2008 - Paediatric respiratory epidemiology I: primary ciliary dyskinesia, sleep-disordered breathing, exercise-induced symptoms and rare diseases
Year: 2008

COPD, asthma and C-reactive protein
Source: Eur Respir J 2006; 27: 874-876
Year: 2006


The role of systemic markers of inflammation in bronchiectasis.
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019


Differences in cellular expression of C-reactive protein and serum amyloid A in lung tissue in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012


Factors affecting C-reactive protein levels in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007


High-sensitive C-reactive protein is associated with reduced lung function in young adults
Source: Eur Respir J 2009; 33: 382-388
Year: 2009



Are C-reactive protein levels associated with bacteria in COPD exacerbations?
Source: Eur Respir J 2015; 45: 1514-1515
Year: 2015


Are C-reactive protein levels associated with bacteria in COPD exacerbations?
Source: Eur Respir J 2015; 45: 1515-1516
Year: 2015


Vascular wall remodeling in patients with chronic thromboembolic pulmonary hypertension: a role for C-reactive protein
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008


C-reactive protein and serum amyloid A overexpression in lung tissues of chronic obstructive pulmonary disease patients
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012